Navigation Links
Rodobo International, Inc. to Present at Rodman & Renshaw Conference in Beijing on March 8, 2010
Date:3/5/2010

HARBIN, China, March 5 /PRNewswire-Asia-FirstCall/ -- Rodobo International, Inc. (OTC Bulletin Board: RDBO) ("Rodobo" or the "Company"), a U.S. company with wholly-owned fast growing Chinese operating companies engaged in the production, processing, distribution and development of high quality milk formula products in the People's Republic of China for infants, children, middle-aged and elderly, today announced that it will present at the Rodman & Renshaw Annual China Equities Conference. The conference will take place March 7-9, 2010, at the Regent Hotel in Beijing, China. Rodobo is scheduled to present in Ballroom 1 on Monday March 8, 2010 at 2:50 p.m. Beijing Time and the Company's Chairman and Chief Executive Officer, Mr. Wang Yanbin, and Chief Financial Officer, Ms. Xiuzhen Qiao will be in attendance. Investors interested in attending Rodman & Renshaw event should contact their Rodman & Renshaw sales representative. For more information about the conference, please visit http://www.rodmanandrenshaw.com/conferences?id=49 .

About Rodobo International, Inc.:

Rodobo is one of the leading independent dairy companies in China. Through its wholly-owned operating subsidiary, Rodobo is a producer and distributor of high-quality formula milk powder products for infants, children, pregnant women, nursing mothers, middle aged and the elderly in China. The Company's products are sold under the brand name 'Rodobo' and are produced in cutting edge facilities using the highest industry standards and the best quality control systems.

Safe Harbor Statement:

This press release contains forward-looking statements. Whenever we use words such as 'believe,' 'expect,' 'anticipate,' 'intend,' 'plan,' 'estimate' or similar expressions, we are making forward-looking statements. Forward- looking statements include statements regarding our goals, beliefs, future growth strategies, objectives, plans or current expectations. These forward- looking statements are based on the current expectations of the management of Rodobo only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward- looking statements: failure to obtain required regulatory approvals; risks associated with the effect of changing economic conditions and/or regulatory environment in the People's Republic of China; variations in cash flow; reliance on collaborative partners and on new product development; variations in new product development; risks associated with rapid technological change and the potential of introduced or undetected flaws and defects in products; changes in technology and market requirements; loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of Rodobo to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Rodobo undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting Rodobo, reference is made to Part I, Item 1A, 'Risk Factors' of Rodobo's Annual Report on Form 10-K for the fiscal year ended September 30, 2009 and to other reports filed from time to time by Rodobo with the Securities and Exchange Commission.

    For more information, please contact:

     Xiuzhen Qiao
     Rodobo International, Inc.
     Tel:   +86-451-8226-5922
     Email: qiaozhen1973@163.com

SOURCE Rodobo International, Inc.

Back to top

RELATED LINKS
http://www.rodmanandrenshaw.com/conferences?id=49

'/>"/>

SOURCE Rodobo International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Rodobo International, Inc. Reports Q2 and First Half of 2009
2. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
3. Vita-Tech International, Inc. Donates One Ton of Vitamins To Polio Treatment Centers in Guinea, West Africa
4. HeartWare International, Inc. Temporary Suspension of Trading
5. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
6. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
7. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. Cryo-Cell International, Inc. Reports First Quarter 2009 Results
10. MINRAD International, Inc. Announces Reduction in Workforce
11. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
Breaking Biology Technology:
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, 2017 ... and 23andMe , the leading personal genetics company, ... Zipongo can now provide customers with personalized nutrition plans ... and biometrics, but also genetic markers impacting how their ... Zipongo,s personalized food decision support platform uses biometrics such ...
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
Breaking Biology News(10 mins):